Related references
Note: Only part of the references are listed.Kinetic efficiency: the missing metric for enhancing compound quality?
Geoffrey A. Holdgate et al.
DRUG DISCOVERY TODAY (2011)
Effects of cyclin-dependent kinase 8 specific siRNA on the proliferation and apoptosis of colon cancer cells
Song-Bing He et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
The Structure of CDK8/CycC Implicates Specificity in the CDK/Cyclin Family and Reveals Interaction with a Deep Pocket Binder
E. V. Schneider et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
Shielded Hydrogen Bonds as Structural Determinants of Binding Kinetics: Application in Drug Design
Peter Schmidtke et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Molecular replacement with MOLREP
Alexei Vagin et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
XDS
Wolfgang Kabsch
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
Recent developments in cyclin-dependent kinase biochemical and structural studies
Aude Echalier et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
The design, synthesis, and evaluation of 8 hybrid DFG-out allosteric kinase inhibitors: A structural analysis of the binding interactions of Gleevec®, Nexavar®, and BIRB-796
Justin Dietrich et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Structural dissection of cyclin dependent kinases regulation and protein recognition properties
Graziano Lolli
CELL CYCLE (2010)
Halogen Bonds Form the Basis for Selective P-TEFb Inhibition by DRB
Sonja Baumli et al.
CHEMISTRY & BIOLOGY (2010)
Drug-target residence time: critical information for lead optimization
Hao Lu et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2010)
Through the Gatekeeper Door: Exploiting the Active Kinase Conformation
Fabio Zuccotto et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
The histone variant macroH2A suppresses melanoma progression through regulation of CDK8
Avnish Kapoor et al.
NATURE (2010)
CDK8 is a positive regulator of transcriptional elongation within the serum response network
Aaron J. Donner et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
CDK8 A positive regulator of transcription
Matthew D. Galbraith et al.
TRANSCRIPTION-AUSTIN (2010)
Revving the Throttle on an Oncogene: CDK8 Takes the Driver Seat
Ron Firestein et al.
CANCER RESEARCH (2009)
Fragment-based lead generation: identification of seed fragments by a highly efficient fragment screening technology
Lars Neumann et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2009)
Development of a Fluorescent-Tagged Kinase Assay System for the Detection and Characterization of Allosteric Kinase Inhibitors
Jeffrey R. Simard et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Residence time of receptor-ligand complexes and its effect on biological function
Peter J. Tummino et al.
BIOCHEMISTRY (2008)
Small-molecule inhibitors binding to protein kinase. Part II: the novel pharmacophore approach of type II and type III inhibition
A. C. Backes et al.
EXPERT OPINION ON DRUG DISCOVERY (2008)
E2F1 represses β-catenin transcription and is antagonized by both pRB and CDK8
Erick J. Morris et al.
NATURE (2008)
CDK8 is a colorectal cancer oncogene that regulates β-catenin activity
Ron Firestein et al.
NATURE (2008)
CDK8 is a stimulus-specific positive coregulator of p53 target genes
Aaron Joseph Donner et al.
MOLECULAR CELL (2007)
Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism
Alexandr P. Kornev et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Opinion - Drug-target residence time and its implications for lead optimization
Robert A. Copeland et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Rational design of inhibitors that bind to inactive kinase conformations
Y Liu et al.
NATURE CHEMICAL BIOLOGY (2006)
Exploiting structural principles to design cyclin-dependent kinase inhibitors
M Noble et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2005)
Three cyclin-dependent kinases preferentially phosphorylate different parts of the C-terminal domain of the large subunit of RNA polymerase II
R Pinhero et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2004)
Thermal denaturation:: A method to rank slow binding, high-affinity p38α MAP kinase inhibitors
RR Kroe et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Structure-activity relationships of the p38α MAP kinase inhibitor 1-(5-tert-Butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)naphthalen-1-yl]urea (BIRB 796)
J Regan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Dynamics and binding modes of free cdk2 and its two complexes with inhibitors studied by computer simulations
M Otyepka et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2002)
The conformational plasticity of protein kinases
M Huse et al.
CELL (2002)
Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site
C Pargellis et al.
NATURE STRUCTURAL BIOLOGY (2002)
TFIIH is negatively regulated by cdk8-containing mediator complexes
S Akoulitchev et al.
NATURE (2000)
Share Paper
